Oncternal Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Oncternal Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q3 2024.
  • Oncternal Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.85M, a 7.98% increase year-over-year.
  • Oncternal Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $6.81M, a 3.81% decline year-over-year.
  • Oncternal Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.5M, a 0.93% increase from 2022.
  • Oncternal Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.43M, a 26.5% increase from 2021.
  • Oncternal Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.88M, a 278% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $6.81M $1.85M +$137K +7.98% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $6.68M $1.38M -$298K -17.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $6.98M $1.36M -$525K -27.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $7.5M $2.22M +$416K +23.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $7.08M $1.72M -$257K -13% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $7.34M $1.68M +$3K +0.18% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $7.34M $1.89M -$93K -4.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $7.43M $1.8M +$89K +5.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $7.34M $1.97M +$486K +32.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $6.86M $1.68M -$159K -8.66% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $7.02M $1.98M +$1.14M +136% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $5.88M $1.71M +$1.31M +321% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $4.57M $1.49M +$1.08M +266% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $3.49M $1.84M +$1.49M +435% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $2M $838K +$439K +110% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $1.56M $407K +$92K +29.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 $1.46M $407K +$317K +352% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $1.15M $343K +$280K +444% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $867K $399K +$360K +923% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $507K $315K +$906K Oct 1, 2019 Dec 31, 2019 10-K/A 2021-03-12
Q3 2019 -$399K $90K +$48K +114% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$447K $63K +$22K +53.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$469K $39K -$649K -94.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $180K -$591K -$1.56M -161% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 $1.74M $42K -$902K -95.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $2.64M $41K -$660K -94.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $3.3M $688K -$16K -2.27% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $3.32M $968K +$289K +42.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 $3.03M $944K +$92K +10.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $2.94M $701K -$113K -13.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $3.05M $704K -$40K -5.38% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $3.09M $679K -$101K -12.9% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 $3.19M $852K +$98K +13% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $3.09M $814K +$65K +8.68% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $3.03M $744K +$294K +65.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $2.73M $780K +$507K +186% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-13
Q3 2015 $2.23M $754K +$488K +183% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $1.74M $749K -$1.02M -57.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $2.76M $450K -$1.8M -80% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $4.55M $273K -$1.26M -82.2% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-24
Q3 2014 $5.82M $266K -$496K -65.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $6.31M $1.77M +$1.05M +147% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $5.26M $2.25M +$1.39M +163% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $3.87M $1.54M +$725K +89.4% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 $3.14M $762K -$31K -3.91% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $3.17M $714K +$428K +150% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $2.75M $856K -$71K -7.66% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $2.82M $811K Oct 1, 2012 Dec 31, 2012 10-K 2015-03-16
Q3 2012 $793K -$333K -29.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $286K -$657K -69.7% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-22
Q1 2012 $927K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-06
Q3 2011 $1.13M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $943K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.